Abiopharma

New Form S-8 - RHYTHM PHARMACEUTICALS, INC. Filed: 2026-01-16 AccNo: 0001104659-26-004322 Size: 420 KB

New Form 424B5 - Tiziana Life Sciences Ltd Filed: 2026-01-16 AccNo: 0001213900-26-004895 Size: 503 KB

(99% Neutral) Arbutus Biopharma Corporation (ABUS) Announces Update on Collaboration with Registrant

(99% Neutral) Autonomix Medical Inc. (AMIX) Files Form 8-K

New Form SCHEDULE 13G - Adlai Nortye Ltd. Filed: 2026-01-16 AccNo: 0001213900-26-004890 Size: 7 KB

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date

Brookdale Senior Living Inc. - Brookdale Announces 2026 Investor Day and Webcast

Brookdale Announces 2026 Investor Day and Webcast

AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation

Sharps Technology Strengthens Market Confidence with Advisor Lock-Up Agreement

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million

(99% Neutral) Chemours Co (CC) Announces Business Combination

(80% Positive) Cara Therapeutics (CARA) Announces Clinical Development Update

New Form EFFECT - MetaVia Inc. Filed: 2026-01-15 AccNo: 9999999995-26-000181 Size: 1 KB